Structural MRI of the basal forebrain as predictor of cognitive response to galantamine in healthy older adults—A randomized controlled double‐blinded crossover study-Reference-Cited by-同舟云学术

Structural MRI of the basal forebrain as predictor of cognitive response to galantamine in healthy older adults—A randomized controlled double‐blinded crossover study

Published:2021-01 Issue:1 Volume:7 Page:
ISSN:2352-8737
Container-title:Alzheimer's & Dementia: Translational Research & Clinical Interventions
language:en
Short-container-title:A&D Transl Res & Clin Interv

Author:

Müller Patrick¹²,Vellage Anne‐Katrin¹³,Schmicker Marlen¹,Menze Inga¹,Grothe Michel J.⁴⁵,Teipel Stefan J.⁴,Müller Notger G.¹²⁶

Affiliation:

1. German Centre for Neurodegenerative Diseases Magdeburg Germany

2. Department of Neurology Otto von Guericke University Magdeburg Germany

3. Berlin School of Mind and Brain Humboldt‐University Berlin Germany

4. German Centre for Neurodegenerative Diseases Rostock Germany

5. Unidad de Trastornos del Movimiento Servicio de Neurología y Neurofisiología Clínica Instituto de Biomedicina de Sevilla Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla Seville Spain

6. Center for Behavioral Brain Science (CBBS) Magdeburg Germany

Publisher

Wiley

Subject

Psychiatry and Mental health,Neurology (clinical)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/trc2.12153

Reference41 articles.

1. Alzheimer's disease

2. Working memory, attention, and executive function in Alzheimer’s disease and frontotemporal dementia

3. Nucleus basalis of Meynert revisited: anatomy, history and differential involvement in Alzheimer’s and Parkinson’s disease

4. Pharmakologische Therapie der Alzheimer-Demenz

5. An update on the pharmacology of galantamine

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of Basal Forebrain Atrophy With Cognitive Decline in Early Alzheimer Disease;Neurology;2024-07-23

2. Longitudinal trajectories of basal forebrain volume in normal aging and Alzheimer’s disease;Neurobiology of Aging;2023-12

3. Modes of Acetylcholine Signaling in the Prefrontal Cortex: Implications for Cholinergic Dysfunction and Disorders;Acetylcholine - Recent Advances and New Perspectives;2023-09-27

4. Preclinical and randomized clinical evaluation of the p38α kinase inhibitor neflamapimod for basal forebrain cholinergic degeneration;Nature Communications;2022-09-21

5. Age and Anterior Basal Forebrain Volume Predict the Cholinergic Deficit in Patients with Mild Cognitive Impairment due to Alzheimer’s Disease;Journal of Alzheimer's Disease;2022-03-08